Larry Heaton has more than 35 years of executive leadership and operations experience from the therapeutic, medical device, and biotechnology industries, with an extensive focus on business, product development, and commercialization at both large-cap and early-stage medical device companies.

Most recently, Heaton was President, Chief Executive Officer, and Director of Flowonix, Inc., a privately held company marketing implantable drug-delivery systems for the management of pain and spasticity. Prior to that, he was President, Chief Executive Officer, and Director of Cardiox Corporation, a privately held company that developed and marketed drug-device combination products for the structural heart and liver diagnostics markets. He also has served as President, Chief Executive Officer, and Chairman of the board of Vioptix Inc., a privately held company in the tissue oximetry field, President, Chief Executive Officer, and Director of Curon Medical, Inc., a public company marketing products for the treatment of gastrointestinal disorders, and President, Chief Executive Officer, and Director of Response Genetics, Inc., an applied genomics start-up firm providing gene expression services in the oncology market.

His earlier career spanned 18 years at United States Surgical Corporation (USSC), a leading manufacturer of innovative wound closure and advanced surgical products, serving in roles of increasing responsibility in Sales, Marketing, and General Management. His career at USSC culminated in his serving as President and Chief Operating Officer of USSC from 1998 through 2000.

Heaton was awarded a Bachelor of Arts degree from Eastern Illinois University and is an inventor on several U.S. patents. He has served as a member of the board of several international medical societies and foundations, including the MITAC Board for the commercialization of NASA technology via partnerships with the medical industry.

Mr. Donato joined Zomedica (NYSE-ZOM) in March 2023. Mr. Donato has over 30 years of experience including over 20 years of both public and private executive leadership roles primarily in the human life sciences space. Most recently prior to joining ZOM, Mr. Donato was an executive vice president of Cincinnati based Standard Bariatrics, a start-up surgical device company specializing in bariatric surgery. While there, the company successfully exited in late 2022 with a sale to Teleflex (TFX) in a deal valued at up to $300M. Mr. Donato served in similar capacity at Philadelphia based Neuronetics (STIM) a leader in transcranial magnetic stimulation for depression where he co-led the Company’s successful IPO in 2018. Mr. Donato executive experience includes Assurex Health, Bovie medical (now APYX), Cyberonics (now LIVA), and Iris International (formerly IRIS).

Mr. Donato graduated magna cum laude from the Fisher College of Business at THE Ohio State University and an MBA from the University of Akron.

Tony Blair recently joined Zomedica in January 2022. Prior to joining Zomedica, he was a principal founder of BGA Mfg. Services LLC, a manufacturing and operations consulting organization. Blair was COO of Cardiox Corporation from 2012 through 2016, a privately held company that developed, manufactured, and marketed drug-device combination products for the structural heart and liver markets. Blair has more than 30 years of operations leadership experience in the medical device and pharmaceutical industries.

Before joining Cardiox in 2012, Blair served as VP of Manufacturing for Devicor Medical Products, the parent corporation of Mammotome, a global company dedicated to acquiring and growing healthcare companies which subsequently acquired Neoprobe, a public company, where he served as Vice President, of Manufacturing Operations.

Prior to Neoprobe, from 2002 to 2004, Blair served as Vice President of Manufacturing at Enpath Medical, the company that acquired Biomec Cardiovascular, Inc.

From 1998 through 2001, Blair led the manufacturing efforts at Astro Instrumentation, a medical device contract manufacturer. He was part of the leadership of the company from its initial start-up in 1998. Prior to Astro, he spent 10 years at Ciba-Corning Diagnostics (now Bayer) in various managerial capacities including Operations Manager, Materials Manager, Purchasing Manager, and Production Supervisor. Before that, he was employed by Bailey Controls and held various positions increasing in responsibility in purchasing and industrial engineering. Blair started his career at Fisher Body, a division of General Motors, in production supervision.

He holds a Bachelors’s degree in Business Administration from Cleveland State University.

As General Counsel, Karen DeHaan-Fullerton builds expert strategy across regulatory, risk, and compliance functions at Zomedica, helping to drive the company from a legal perspective.

DeHaan-Fullerton joined Zomedica in June 2022 and brings more than 24 years of diverse legal expertise to the team. After graduating cum laude from the University of Louisville – Louis D. Brandeis School of Law, she practiced with the firm Goldberg & Simpson in Louisville before moving to Indianapolis to practice with Sommer Barnard (later Taft, Stettinus, and Hollister) as an M&A partner. In 2007, she joined Zimmer, Inc. serving in roles of increasing responsibility as Division General Counsel, Assistant General Counsel, Global Businesses and Americas, and Division General Counsel, Zimmer Biomet. In 2016 she joined Elanco Animal Health negotiating and drafting business development agreements for asset purchases, divestitures, licenses, collaborations, co-promotions, and distribution opportunities. DeHaan-Fullerton also provided legal support to the North America commercial and companion animal business units, as well as to the corporate secretary’s office. Most recently, DeHaan-Fullerton was the Senior Transaction Attorney, Associate General Counsel for Exactech Inc.

Greg Blair is a dynamic life sciences leader with experience across business development, commercial, product development, and finance roles. He is responsible for building and executing an external innovation strategy to maximize shareholder value.

Blair’s focus is on creating value-added partnerships and acquiring differentiated technology that helps Zomedica’s customers thrive in practice and supports their mission to enhance the veterinary care experience for pets and pet parents.

Blair joined Zomedica from Elanco Animal Health, where he was known for his collaborative approach to creating strategic alliances that built trust and confidence with partners across the industry. While at Elanco, Blair delivered multiple successful transactions, including acquisitions, divestitures, strategic alliances, equity investments, and licensing transactions.

He has dedicated his career to leading teams that deliver innovative solutions for customers with companies such as Johnson and Johnson, Intuitive Surgical, and Enteromedics. Blair’s passion for innovation and pursuit of technologies that solve unmet needs, improve clinicians’ practices and enrich patient lives led him to launch numerous innovative products throughout his career.

Outside of work, Blair enjoys spending quality time with his wife and young son, as well as their Beauceron, Poscoe. He is a private pilot and the family enjoys taking trips around the eastern US to anywhere with a beach and warm weather.

Kevin joined the Zomedica leadership team in November 2023. He brings over 30 years of human and veterinary sales, sales management and marketing experience, primarily in the diagnostic space.

Prior to Zomedica, Kevin was Vice-President of US Sales at Heska, Inc, where he devoted his energy and resources to growing sales until their acquisition by Mars in 2023. At Heska, he transformed multiple sales regions before moving into the VP of sales position. Kevin worked closely with marketing and lead the sales team through several strategic course changes and product launches.

Prior to Heska, Kevin held sales, sales management and marketing positions in human healthcare at Siemens, Johnson & Johnson, and Abbott Diagnostics. He held a key position with IDEXX opening Canadian sales and then moved into a worldwide marketing position.

In his free time, Kevin enjoys hiking and other fitness activities with his wife, Julie and spending time with his two daughters.

Adrian Lock joined the Zomedica leadership team in October 2021 when the company he founded in 2009, Pulse Veterinary Technologies, LLC (“PulseVet”), was acquired. He brings over 30 years of biotechnology sales, marketing, and executive leadership experience in both human and veterinary healthcare to the organization.

Prior to PulseVet, Lock was Vice-President of Sales and Marketing with Sanuwave, where he devoted his energy and resources to developing and commercializing shock wave technology. While at Sanuwave he took over the veterinary division, allowing him to combine his training and background with his lifelong passion for animals. In 2009 the veterinary division of Sanuwave split to form PulseVet. As Director of Global Marketing with CryoLife, he launched BioGlue ® Surgical Adhesive in 2001. BioGlue is a life-saving product now recognized as the leading surgical adhesive in worldwide clinical use for indications in cardiovascular, neurological, and soft tissue surgeries.

Prior to starting his healthcare career, Lock served in the US Navy as a nuclear-trained submarine officer, where he was awarded a Navy Achievement Medal and a Navy Commendation Medal for his service aboard 2 submarines, USS Flying Fish (SSN673), USS Scranton (SSN756), and as a Watch Officer at ComSubLant.

Lock holds a BS degree in Engineering Science from Vanderbilt University, which he attended on a Navy ROTC scholarship.

In his free time, Lock enjoys playing guitar, fitness/outdoor activities, and spending time with his wife, Rhonda, four daughters, two granddaughters, two dogs, and a cat.

Mike Zuehlke joined Zomedica in July 2022 as the Corporate Controller. He holds a B.A. in Business Administration from Alma College and an MBA from the Ross School of Business at the University of Michigan. His career began in public accounting at EY and he has since held series of Accounting and Finance roles of progressing responsibility for both publicly traded and private companies. In addition to these accomplishments, Mike is also a registered certified public accountant in the state of Michigan.

Most recently, Mike was the Corporate Controller for Guardian Alarm, a top 15 security alarm company in the country. At Guardian, Mike was integral in the divestiture of the company’s personal emergency response systems (PERS) business, the refinance of a $100 million line of credit, and the acquisitions of two regional alarm companies.

He and his wife are the proud parents of two boys, who are both very active in travel hockey and baseball. He enjoys coaching their teams and golfing.

Nicole Westfall brings more than 25 years of experience in marketing, sales, and communications covering the gamut of marketing arenas from corporate communications to product management to event planning to media. Passionate about animal health, she has spent the last decade working with various manufacturers to spread the word about their products and services.

Most recently, Westfall was the Senior Director of Sales and Marketing for Assisi Animal Health, a privately held company specializing in TPEMF medical devices to help pets live better pain and anxiety-free lives. She has also served as Associate Director of Marketing for PRN Pharmacal with a focus on marketing their flagship product, PROIN, along with their line of nutraceuticals for inflammation and pain.

Westfall spent her earlier career in various forms of the marketing and media realm. She successfully ran her own marketing/advertising agency for 15 years but also spent time on the media side of the business. She has been published in over 100 publications as well as worked in various positions in television and radio.

Westfall holds a Bachelor’s Degree in Communications from Baylor University and an MBA in International Business from the University of Texas, Arlington.

Trudy Gage joined the Zomedica leadership team in October 2021 when the company, Pulse Veterinary Technologies, LLC (“PulseVet”), was acquired. She resides in the Thumb of Michigan, where she owns and operates Gage Show Horses, a small horse farm, where she breeds, shows, and loves a few select Quarter Horses. Gage is proud to be named as the Breeder on some world class horses and enjoys watching them go on and find success in the Show Ring. Gage herself was awarded a top ten placing (3rd) at the prestigious All-American Pen Quarter Horse Congress in 2022. Gage made her debut in Ranch Riding pen with High Brow Legend, aka Wiley.

Gage has been passionate about horses her entire life, starting with a pony as a young child, her parents often jokingly say, most children outgrow this! Gage is more passionate than ever, continuing what she calls a life-long journey of continuous learning shared with her beloved horses. Gage has been involved in many equine-related world-class careers, joining PulseVet in 2009, her history includes working as a certified riding instructor, holding several judges’ cards, and even hosting a radio show called “Horsing Around with Trudy”. She is looking forward to raising more babies she is expecting in 2024, with plans to compete at some Quarter Horse Shows this year. The only other thing Gage is passionate about is dogs! From fundraising to fostering, Gage has been involved with many rescue dog groups; she is happy to help. Gage shares her farm and home with her border collie Snickers and plans to add another border collie family member or two, very soon!

Evan St. Peter joined Zomedica in September of 2018 to lead the development of a cloud-based data platform to capture data from Zomedica’s diagnostic devices. This platform is known as MyZomedica™ today. He now leads the company’s technology innovation for both Zomedica’s customer-facing digital technology as well as Zomedica’s internal technology needs.

Prior to joining Zomedica, St. Peter was part of the Connected Care team within Stryker’s Medical and Surgical Division, where he helped lead the delivery of Stryker’s customer-facing IoT and machine learning application called Smart Equipment Management. During his time at Stryker, he was responsible for leading Agile application development across onshore and offshore development teams as well as the statistical validation of supervised machine learning models to identify surgical devices that would benefit from preventative maintenance. In addition to his time at Stryker, St. Peter brings operations and enterprise IT experience from his time at MPI Research, where he held roles of increasing responsibility throughout his career there.

St. Peter holds a Bachelor of Science in Biology from Northern Michigan University and a Master of Business Administration from Western Michigan University. He is the father of two boys. He and his wife enjoy family camping and home DIY, and he is an avid cyclist.

Ashley Wood joined Zomedica in 2019 to facilitate the development of BAW technology for use in veterinary medicine. She now leads the company’s research and development activities. Wood’s expertise is in the areas of molecular biology, cell biology, imaging techniques, and biochemistry.

Prior to her current role, Wood was part of the R&D group at Swift Biosciences, where she was responsible for creating market viable products as the lead scientist in the advancement of next-generation sequencing assays. Her responsibilities included assay development, bioinformatic analysis, and transfer to manufacturing.

Wood also served as a research assistant professor and completed a postdoctoral research fellowship (awarded by the American Cancer Society) in the Cell & Molecular Biology department at Northwestern University’s Feinberg School of Medicine. She has co-authored several papers that have appeared in industry-prominent journals.

Wood graduated with honors from Duke University with a degree in biochemistry and earned a Ph.D. in molecular biology from Johns Hopkins University. She is the mother of two young boys, and when she’s not transporting them to hockey, baseball, or other activities, she enjoys cooking, running, and spending time outdoors.

Bill Campbell joined Zomedica in July 2022 with over 50 years of experience in senior leadership roles and product design. Campbell is the holder of many patents for medical equipment in the human and veterinary markets. He founded RemoteVet LLC in 1988, a company that developed web-based ultrasound and digital x-ray products. RemoteVet installed products in over 2,000 veterinary hospitals. In 2004, after a successful growth period, he sold RemoteVet to Medical Management International. At the time they operated nearly 700 veterinary hospitals under the trade name Banfield. Campbell then served as Senior VP of Technology for Banfield.

Campbell started Revo Squared in 2009 to enhance the development of digital radiography products. After developing the only dual-resolution digital x-ray system Campbell started the development of MicroView, the world’s first fully automated digital microscope. MicroView dramatically improves the diagnostic value of blood smears, cytologic aspirates, and other tissue samples normally observed using light microscopy. This patented microscope allows, for the first time, the automated preparation and immediate diagnosis of fresh blood smears and cytology samples at the point of care.

Frederic (Tripp) Almy joined Zomedica in August of 2023 to lead the Clinical Pathology department in support of the TruView automated digital microscope. Prior to joining Zomedica, Dr. Almy was most recently a senior toxicological clinical pathologist and the Director of Digital Clinical Pathology and Artificial Intelligence for Clinical Pathology at Charles River Laboratories. Preceding his time at Charles River, Dr. Almy was Scientific Director and Head of Clinical Pathology at Janssen Pharmaceuticals (JNJ). Before making the switch to toxicological pathology, Dr. Almy was an Associate Professor and Chief of the Clinical Pathology Service, Residency Coordinator, and Director of the Cytology and Hematology Immunophenotyping Laboratory at the College of Veterinary Medicine at The University of Georgia. Prior to that, he was an Assistant Professor and Chief of Service at the Virginia-Maryland Regional College of Veterinary Medicine. Dr. Almy also has reference laboratory experience as a staff clinical pathologist and Hematology Section Chief for Idexx Veterinary Services’ California lab. Dr. Almy holds a Doctor of Veterinary Medicine from the The University of Georgia and a Master of Science in Comparative Pathology from the University of California, Davis. Dr. Almy is ACVP board- certified in clinical pathology. He lives with his wife and their son and daughter on a working farm in the Blue Ridge Mountains of Virginia